FOLH1 and posterior cortical atrophy: Recently, it was found that the response of prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/CT to primary PCa lesions after neoadjuvant therapy could predict the pathological response, which might be helpful for the selection of patients to perform RP.